Atheline Major-Pedersen

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Diabetes, obesity & metabolism

Pharmacoepidemiology and drug safety

Novo Nordisk AS

Universtiy of Copenhagen, faculty of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novo Nordisk AS

Denmark

Principal Specialist :: Safety Surveillance

Education History

Universtiy of Copenhagen, faculty of Medicine

Denmark

PHD

Publications

Jean-François Yale, Atheline Major-Pedersen, Andrei-Mircea Catarig, Rashmi Jain, Markus Menzen, Patrick Holmes
Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme. Diabetes, obesity & metabolism (2024)
Paolo Sbraccia, Jens Aberle, Anne Helene Olsen, Naveen Rathor, Atheline Major-Pedersen
Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study. Diabetes, obesity & metabolism 25 (4) (2023)
Paolo Sbraccia, Jens Aberle, Anne Helene Olsen, Naveen Rathor, Atheline Major-Pedersen
Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study. Diabetes, obesity & metabolism 25 (4) (2023)
Paolo Sbraccia, Jens Aberle, Anne Helene Olsen, Naveen Rathor, Atheline Major-Pedersen
Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study. Diabetes, obesity & metabolism 25 (4) (2023)
Paolo Sbraccia, Jens Aberle, Anne Helene Olsen, Naveen Rathor, Atheline Major-Pedersen
Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study. Diabetes, obesity & metabolism (2022)
Paolo Sbraccia, Jens Aberle, Anne Helene Olsen, Naveen Rathor, Atheline Major-Pedersen
Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study. Diabetes, obesity & metabolism (2022)
Atheline Major-Pedersen, Mary Kate McCullen, Mary Elizabeth Sabol, Omolara Adetunji, Joseph Massaro, Alfred I Neugut, Julie Ann Sosa, Anthony N Hollenberg
A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting. Pharmacoepidemiology and drug safety 30 (1) (2020)

Atheline Major-Pedersen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Atheline Major-Pedersen